Filtered By:
Cancer: Bile Duct Cancer
Infectious Disease: Hepatitis B
This page shows you your search results in order of date.
Order by Relevance | Date
Total 50 results found since Jan 2013.
Viral hepatitis increases the risk of cholangiocarcinoma: a systematic review and meta-analysis
CONCLUSIONS: HBV and HCV infection could increase the risk of CCA. Therefore, in clinical practice, attention should be paid to CCA screening and early prevention of HBV and HCV infected patients.PMID:37434689 | PMC:PMC10331712 | DOI:10.21037/tcr-23-892
Source: Cancer Control - July 12, 2023 Category: Cancer & Oncology Authors: Bin Lin Qiongxiao He Yidan Lu Wanyi Zhang Jianwei Jin Haiyan Pan Source Type: research
De Novo Intrahepatic Cholangiocarcinoma After Deceased Donor Liver Transplant in an Adult Patient
Exp Clin Transplant. 2022 Mar;20(3):316-320. doi: 10.6002/ect.2021.0437.ABSTRACTSurvival after liver transplant has progressively improved over recent decades. Recurrent or de novo malignancy, however, remains a major cause of patient death after transplant. Here, we have described a patient who developed de novo intrahepatic cholangiocarcinoma in the graft liver after orthotopic liver transplant. The 48-year-old male patient had end-stage liver disease from hepatitis B-related liver cirrhosis and a Model for End-Stage Liver Disease score of 26 and was listed for liver transplant. Recurrent esophageal variceal hemorrhage, ...
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - March 30, 2022 Category: Transplant Surgery Authors: Hyung Hwan Moon Dong Hoon Shin Young Il Choi Source Type: research
Challenges and opportunities in the application of artificial intelligence in gastroenterology and hepatology
In this study, we comprehensively review the current applications of AI/ML-based models in these fields and the opportunities that arise from their application. Specifically, we refer to the applications of AI/ML-based models in prevention, diagnosis, management, and prognosis of gastrointestinal bleeding, inflammatory bowel diseases, gastrointestinal premalignant and malignant lesions, other nonmalignant gastrointestinal lesions and diseases, hepatitis B and C infection, chronic liver diseases, hepatocellular carcinoma, cholangiocarcinoma, and primary sclerosing cholangitis. At the same time, we identify the major challen...
Source: World Journal of Gastroenterology - October 29, 2021 Category: Gastroenterology Authors: Chrysanthos D Christou Georgios Tsoulfas Source Type: research
Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?
World J Gastroenterol. 2021 Jul 21;27(27):4252-4275. doi: 10.3748/wjg.v27.i27.4252.ABSTRACTIntrahepatic cholangiocarcinoma (iCCA) is a subgroup of cholangiocarcinoma that accounts for about 10%-20% of the total cases. Infection with hepatitis B virus (HBV) is one of the most important predisposing factors leading to the formation of iCCA. It has been recently estimated based on abundant epidemiological data that the association between HBV infection and iCCA is strong with an odds ratio of about 4.5. The HBV-associated mechanisms that lead to iCCA are under intense investigation. The diagnosis of iCCA in the context of chr...
Source: World Journal of Gastroenterology : WJG - August 9, 2021 Category: Gastroenterology Authors: Nikolaos Fragkou Lazaros Sideras Panteleimon Panas Christos Emmanouilides Emmanouil Sinakos Source Type: research
